InvestorsHub Logo
Followers 4
Posts 73
Boards Moderated 0
Alias Born 11/02/2020

Re: powerwalker post# 386490

Wednesday, 11/30/2022 2:41:12 PM

Wednesday, November 30, 2022 2:41:12 PM

Post# of 461441
Can one of the board experts confirm the followng quote from the Guggenheim presentation was completely new information? Specifically about the results of 30mg and 50mg dosage in the PDD trial. And is he referring to the blinded or open label portion?

"I want you to remember the numbers of the doses here for a reason... placebo declined... the medium dose stopped the decline... but the high dose group was above baseline... so patients coming into the trial came out with better cognitive features. And the reason I want you to remember these doses is that it's exactly the same doses as in the upcoming Alzheimer's study. Placebo, thirty, fifty."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News